CME vs DBD · P/E 22, rev $6.52B vs P/E 28, rev $3.75B
CME Group Inc (CME) versus Diebold Nixdorf, Incorporated (DBD) — a side-by-side from cached financials, not a winner call.
CME Group Inc (CME) is a financial data & stock exchanges company listed on NASDAQ.
Diebold Nixdorf, Incorporated (DBD) is a software - application company listed on US.
Latest reported CME revenue for 2025-12-31 was $6.52B. Net income was $4.07B. Revenue was up 6.4% from 2024-12-31 to 2025-12-31. CME currently screens at market cap $91.25B and trailing P/E 21.9.
Latest reported DBD revenue for 2024-12-31 was $3.75B. Net income was -$14.5M. Revenue was up 130.3% from 2023-12-31 to 2024-12-31. DBD currently screens at market cap $2.82B and trailing P/E 28.1.
CME currently screens at market cap $91.25B and trailing P/E 21.9. DBD currently screens at market cap $2.82B and trailing P/E 28.1.
Not investment advice. Open the CME and DBD stock pages for the full models.
Not investment advice.